Posted by Michael Wonder on 20 Oct 2021
PHARMAC says all patients who meet criteria will get next generation diabetes drugs, despite concerns
20 October 2021 - PHARMAC says it will fund next generation diabetes drugs for all people with the condition who meet its criteria, despite new concerns raised by patient advocates.
The agency announced in December it would fund empagliflozin or dulaglutide for an estimated 53,000 patients with the disease who met certain criteria, starting in February.
